Patient Follow-Up and Monitoring Medicines I. Ralph Edwards Editorial 29 December 2012 Pages: 1121 - 1123
Putting the Cardiovascular Safety of Aromatase Inhibitors in Patients with Early Breast Cancer into Perspective Muhammad YounusMichelle KissnerNicola Wallis Review Article 29 December 2012 Pages: 1125 - 1149
Thrombocytopenia in Adult Cancer Patients Receiving Cytotoxic Chemotherapy Maarten J. ten BergPatricia M.L.A. van den BemtToine C.G. Egberts Short Communication 29 December 2012 Pages: 1151 - 1160
Serotonin Reuptake Inhibitors and Hyperprolactinaemia Thierry TrenqueEmmanuelle HerlemMoustapha Dramé Short Communication 29 December 2012 Pages: 1161 - 1166
Pharmacogenetic Risk for Adverse Reactions to Irinotecan in the Major Ethnic Populations of Singapore Cynthia SungPui Ling LeeDorothy S.L. Toh Short Communication 29 December 2012 Pages: 1167 - 1175
Examining the Utilization and Tolerability of the Non-Sedating Antihistamine Levocetirizine in England Using Prescription-Event Monitoring Data Deborah LaytonVicki Ms OsborneSaad A.W. Shakir Original Research Article 29 December 2012 Pages: 1177 - 1189
Comparing Adverse Event Rates of Oral Blood Glucose-Lowering Drugs Reported by Patients and Healthcare Providers Liana HakobyanFlora M. Haaijer-RuskampPetra Denig Original Research Article 29 December 2012 Pages: 1191 - 1202
Modified Prescription-Event Monitoring Studies Deborah LaytonLorna HazellSaad A.W. Shakir Practical Application Open access 29 December 2012 Pages: e1 - e9